A reason for this could be the lack of therapeutical purpose, as CD8-agonists could lead autoimmune reactions and inhibitors could mitigate the cytotoxic activity against infected cells and tumor cells (besides their potential use against autoreactive T-cells [45]). This evidence concerns the gene CD8A and neoplasm.